-
Gly-Arg-Gly-Asp-Ser TFA
-
BD013018222828433-23-298+%
-
¥3588.0100mg
-
2-((2S,5R,8S,11S)-5-Benzyl-11-(3-guanidinopropyl)-8-isopropyl-7-methyl-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaazacyclopentadecan-2-yl)acetic acid trifluoroacetate
-
BD764816199807-35-798%
-
¥155.01mg
-
2-(4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)acetic acid
-
BD56656167-30-198%
-
¥3337.01g
-
2-((2S,5R,8R,11S)-5-Benzyl-11-(3-guanidinopropyl)-8-(mercaptomethyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaazacyclopentadecan-2-yl)acetic acid
-
BD00963549862772-11-098%
-
¥5216.0100mg
-
(S)-2-((R)-2-((S)-2-((S)-2-((S)-1-Acetylpyrrolidine-2-carboxamido)-3-(1H-imidazol-4-yl)propanamido)-3-hydroxypropanamido)-3-mercaptopropanamido)succinamide
-
BD630599262438-43-798%
-
¥1216.0250mg
-
(S)-2-(2-((S)-2-Amino-5-guanidinopentanamido)acetamido)succinic acid
-
BD11464999896-85-298%
-
¥784.0100mg
-
(S)-2-(2-((S)-2-Amino-5-guanidinopentanamido)acetamido)succinic acid trifluoroacetate
-
BD012973582378808-45-698%
-
¥2566.0100mg
-
2-((2S,5R,8S,11S)-5-Benzyl-11-(3-guanidinopropyl)-8-isopropyl-7-methyl-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaazacyclopentadecan-2-yl)acetic acid
-
BD628662188968-51-698%
-
¥1095.050mg
-
2,2,2-Trifluoroacetic acid compound with 2-((2S,5R,8S,11S)-8-(4-aminobutyl)-11-(3-guanidinopropyl)-5-(4-hydroxybenzyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaazacyclopentadecan-2-yl)acetic acid (2:1)
-
BD764849250612-42-198%
-
¥347.05mg
-
2-Hydroxy-N,N,N-trimethylethan-1-aminium (Z)-4-(5-((3-benzyl-4-oxo-2-thioxothiazolidin-5-ylidene)methyl)furan-2-yl)benzoate
-
BD011363392055362-74-698%
-
¥1098.050mg
-
N-(Cyclopropylmethyl)-4-((4-(6-hydroxy-3,4-dihydroquinolin-1(2H)-yl)pyrimidin-2-yl)amino)benzenesulfonamide
-
BD011729691228445-38-299+%
-
¥1176.0250mg
-
(S)-2-(Butylsulfonamido)-3-(4-(4-(piperidin-4-yl)butoxy)phenyl)propanoic acid hydrochloride hydrate
-
BD154229150915-40-598%
-
¥344.0250mg
-
N-(2-(Ethylsulfonamido)-5-(trifluoromethyl)pyridin-3-yl)cyclohexanecarboxamide
-
BD738842141283-87-698%
-
¥887.05mg
-
2-((2S,5R,8S,11S)-8-(4-Aminobutyl)-11-(3-guanidinopropyl)-5-(4-hydroxybenzyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaazacyclopentadecan-2-yl)acetic acid
-
BD01170104217099-14-498%
-
¥
-
2-(2-Methoxyphenyl)-N-(2-morpholino-5-(morpholinosulfonyl)phenyl)acetamide
-
BD01172999849121-82-098%
-
¥744.05mg
-
(S)-2-(Butylsulfonamido)-3-(4-(4-(piperidin-4-yl)butoxy)phenyl)propanoic acid
-
BD154227144494-65-598%
-
¥1408.0250mg
-
(E)-1-(4-Acetylpiperazin-1-yl)-3-(4-((2-isopropylphenyl)thio)-3-nitrophenyl)prop-2-en-1-one
-
BD01141326280749-17-997%
-
¥3955.0100mg
-
2-((2S,5R,8S,11S)-8-(4-Aminobutyl)-5-benzyl-11-(3-guanidinopropyl)-3,6,9,12,15-pentaoxo-1,4,7,10,13-pentaazacyclopentadecan-2-yl)acetic acid Trifluoroacetate (1:1)
-
BD764848500577-51-598%
-
¥867.010mg
-
(S)-2-(1-(4-(2-(4-(3-(o-Tolyl)ureido)phenyl)acetyl)morpholine-3-carbonyl)piperidin-4-yl)acetic acid
-
BD01110629317353-73-499%
-
¥998.025mg
-
Arg-Gly-Asp-Ser
-
BD11465091037-65-998%
-
¥607.025mg